Avicanna Inc. (AVCN.TO)

CAD 0.34

(1.49%)

Operating Income Summary of Avicanna Inc.

  • Avicanna Inc.'s latest annual operating income in 2023 was -7.93 Million CAD , up 27.42% from previous year.
  • Avicanna Inc.'s latest quarterly operating income in 2024 Q1 was -609.17 Thousand CAD , up 72.29% from previous quarter.
  • Avicanna Inc. reported an annual operating income of -10.57 Million CAD in 2022, up 2.35% from previous year.
  • Avicanna Inc. reported an annual operating income of -10.83 Million CAD in 2021, up 41.55% from previous year.
  • Avicanna Inc. reported a quarterly operating income of -1.75 Million CAD for 2024 Q2, down -167.16% from previous quarter.
  • Avicanna Inc. reported a quarterly operating income of -2.19 Million CAD for 2023 Q4, down -70.7% from previous quarter.

Annual Operating Income Chart of Avicanna Inc. (2023 - 2016)

Historical Annual Operating Income of Avicanna Inc. (2023 - 2016)

Year Operating Income Operating Income Growth
2023 -7.93 Million CAD 27.42%
2022 -10.57 Million CAD 2.35%
2021 -10.83 Million CAD 41.55%
2020 -18.53 Million CAD 18.61%
2019 -22.77 Million CAD -173.57%
2018 -8.32 Million CAD -222.34%
2017 -2.58 Million CAD -8556.05%
2016 -29.83 Thousand CAD 0.0%

Peer Operating Income Comparison of Avicanna Inc.

Name Operating Income Operating Income Difference
Aurora Cannabis Inc. -46.45 Million CAD 82.923%
Avant Brands Inc. -1.45 Million CAD -446.727%
Cardiol Therapeutics Inc. -29.78 Million CAD 73.366%
Crescita Therapeutics Inc. -1.95 Million CAD -305.573%
Knight Therapeutics Inc. -2.89 Million CAD -174.499%
MediPharm Labs Corp. -18.25 Million CAD 56.536%
OrganiGram Holdings Inc. -242.73 Million CAD 96.732%
Canopy Growth Corporation -228.71 Million CAD 96.531%
Willow Biosciences Inc. -13.18 Million CAD 39.819%
Auxly Cannabis Group Inc. -19 Million CAD 58.258%